BEGIN:VCALENDAR
VERSION:2.0
PRODID:https://murmitoyen.com/events/vanille/udem/
X-WR-TIMEZONE:America/Montreal
BEGIN:VEVENT
UID:69e2388230737
DTSTAMP:20260417T094122
DTSTART:20120514T120000
SEQUENCE:0
TRANSP:OPAQUE
DTEND:20120514T120000
URL:https://murmitoyen.com/events/vanille/udem/detail/117145
LOCATION:Université de Montréal - Pavillon Roger-Gaudry\, 2900\, chemin d
 e la Tour\, Montréal\, QC\, Canada\, H3T 1J6
SUMMARY:New drugs targeting the cell envelope of Mycobacterium tuberculosis
DESCRIPTION:Conférence du Dr Mary Jackson (Colorado State University\, USA
 )Mycobacterium tuberculosis (Mtb)\, the causative agent of tuberculosis (T
 B) in humans\, currently infects one‐third of the world's population in 
 its latent form and claims about 1.7 million lives annually making it a le
 ader among the causes of mortality in developing countries. New chemothera
 peutics active against multidrug‐resistant Mtb are urgently needed. This
  talk will summarize the various strategies that have been used over the y
 ears towards anti‐TB drug discovery and the current trends in the field.
  The recent discovery of inhibitors targeting some essential and novel asp
 ects of the cell envelope biosynthesis of Mtb will illustrate this topic.I
 nformationsConférencier invité par le Dr J. Sygusch\, du Département de
  biochimie de la Faculté de médecine.
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Montreal
X-LIC-LOCATION:America/Montreal
END:VTIMEZONE
END:VCALENDAR